Skip to Content

Imagion Biosystems Ltd IBX

Morningstar Rating
A$0.07 −0.01 (9.76%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

IBX is trading at a 53% discount.
Price
A$0.07
Fair Value
A$1.71
Uncertainty
Extreme
1-Star Price
A$4.66
5-Star Price
A$5.33
Economic Moat
Zyk
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if IBX is a good fit for your portfolio.

Trading Information

Previous Close Price
A$0.08
Day Range
A$0.070.08
52-Week Range
A$0.071.44
Bid/Ask
A$0.00 / A$0.00
Market Cap
A$2.42 Mil
Volume/Avg
13,188 / 75,280

Key Statistics

Price/Earnings (Normalized)
Price/Sales
1.37
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Imagion Biosystems Ltd operates in the field of non-invasive detection of specific solid tumor cancers by use of magnetic nanoparticles. The company only operating segment - Research and Development. Its principal business activities consist of nanotechnology, biotechnology, cancer diagnostics and medical imaging using Superparamagnetic Relaxometry. In addition, the company is engaged in the research and development of its clinical phase lead product which is intended for the detection and staging of metastatic HER2 breast cancer.
Sector
Healthcare
Industry
Diagnostics & Research
Stock Style Box
Small Core
Total Number of Employees

Valuation

Metric
IBX
Price/Earnings (Normalized)
Price/Book Value
Price/Sales
1.37
Price/Cash Flow
Price/Earnings
No chart available

Financial Strength

Metric
IBX
Quick Ratio
0.16
Current Ratio
0.27
Interest Coverage
Quick Ratio
IBX

Profitability

Metric
IBX
Return on Assets (Normalized)
Return on Equity (Normalized)
Return on Invested Capital (Normalized)
Return on Assets
IBX
See how this stock stacks up to its competitors with Morningstar Investor

Diagnostics & Research Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
TMO
Thermo Fisher Scientific IncPgwfyszlcwYprv$209.3 Bil
DHR
Danaher CorpWwxgfwtxtdWctnv$182.1 Bil
IQV
IQVIA Holdings IncXtcxwbmhwBwdjmy$42.8 Bil
IDXX
IDEXX Laboratories IncRcdvzcblHwvnqgy$41.5 Bil
A
Agilent Technologies IncCkxmykjhwVfv$40.4 Bil
MTD
Mettler-Toledo International IncGmspdsjhvqMxvjkz$26.5 Bil
ICLR
Icon PLCSmyxyglzCdmbnj$24.8 Bil
ILMN
Illumina IncJypzsmvdTkbtdp$19.5 Bil
WAT
Waters CorpRjykvgkylLgr$18.5 Bil
LH
Laboratory Corp of America HoldingsVtmzwsmvfCmmcsj$16.7 Bil

Sponsor Center